Marrazzo Jeffrey D 4
4 · Prime Medicine, Inc. · Filed May 12, 2023
Insider Transaction Report
Form 4
Marrazzo Jeffrey D
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-10+92,000→ 92,000 totalExercise: $14.04Exp: 2033-05-10→ Common Stock (92,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest in three equal annual installments beginning on May 10, 2024, subject to the Reporting Person's continued service on each such vesting date.